Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 82Genitourinary 76Other hematologic neoplasm 74Gastrointestinal 62Breast 54Thoracic 49CNS 45Gynecologic 29Myeloid 27Head & Neck 26Sarcoma 19Tumor-Agnostic 17Plasma cell 17Dermatologic 16Other solid neoplasm 13Endocrine 8NET 4Classical hematology 3Other 2Other neoplasm 1

Conditions

Obesity 1Inflammation 1Chemotherapy-Induced Peripheral Neuropathy 1Breast Neoplasms 1

Interventions

Tirzepatide 5Educational Status 4Methods 3Interviews as Topic 3Early Intervention, Educational 3semaglutide 2naldemedine 2Standard of Care 2Specimen Handling 2Radiotherapy 2Paclitaxel 2Observation 2Mouthwashes 2Metformin 2Exercise 2Counseling 2Cisplatin 2Carboplatin 2trametinib 1tempol 1sotorasib 1selpercatinib 1polyethylene glycol 3350 1pembrolizumab 1osimertinib 1naloxegol 1mirabegron 1maltodextrin 1ma zi ren wan 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Specimen Handling × Other × Clear all
NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting
112 enrolled
BreastOther

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡